(Press-News.org) A new osteoporosis drug hinders the growth of estrogen-sensitive cancer that has become resistant to treatment with tamoxifen, a study in mice shows. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
The medication, bazedoxifene, which is approved in Europe under the brand name Conbriza for the treatment and prevention of postmenopausal osteoporosis, also reduced estrogen activity and estrogen receptor levels in cultured human breast cancer cells, the study authors reported.
"Bazedoxifene, a known, safe drug approved in Europe, may present a near-term option as an effective therapy for breast cancer in patients who have relapsed during treatment with tamoxifen or aromatase inhibitors," said Suzanne Wardell, PhD, the study's principal investigator and a research scientist at Duke University, Durham, N.C.
About 70 percent of breast cancers are hormone sensitive, the National Cancer Institute estimates, meaning they need female hormones like estrogen to grow. In one-third to one-half of these patients, the cancer becomes resistant to medications that block either estrogen production or activity of the estrogen receptor, according to Wardell, who said, "These women then have few treatment options."
Treatment options include systemic, or whole-body, chemotherapy or often-painful injections of an anti-estrogen drug, fulvestrant into the buttocks muscle.
The investigators reasoned that one or more drugs known as selective estrogen receptor modulators, or SERMs, might prove effective in treating breast tumors that have developed resistance to hormone blockers. Most SERMs have anti-estrogen effects on some tissues and estrogen-like effects on other tissues. The new SERM bazedoxifene stimulates the estrogen receptor in bone to retain bone mineral density but inhibits estrogen receptor activation in the breast and uterus, Wardell said.
Wardell's team tested bazedoxifene in a study funded by the drug's manufacturer, Pfizer. First, they applied standard molecular biology techniques to multiple models of human-derived breast cancer cell lines. The models included cancer cells that were resistant to tamoxifen, aromatase inhibitors and lapatinib, a drug used to treat aggressive HER2-positive breast cancer. In all models, bazedoxifene reportedly inhibited estrogen-induced gene expression and cell proliferation.
The researchers then transplanted the cultured breast tumors into immune-compromised mice. Wardell said that bazedoxifene "completely inhibited the estrogen receptor-dependent tumor growth," not only in tumors that had never received tamoxifen treatment but also in those that were resistant to tamoxifen. The drug deterred tumor growth to a similar extent as reported for fulvestrant, she said.
The ideal next research step, according to Wardell, would be a clinical trial to evaluate the efficacy of bazedoxifene in patients with metastatic, hormone therapy-resistant breast cancer.
Pfizer has applied for U.S. Food and Drug Administration approval of bazedoxifene but only when combined with conjugated estrogens for treatment of postmenopausal symptoms and prevention of postmenopausal osteoporosis, she said.
###
Osteoporosis drug may help treat advanced hormone-sensitive breast cancer
2013-06-17
ELSE PRESS RELEASES FROM THIS DATE:
'Gene signature' test diagnoses benign thyroid growths
2013-06-17
A new genetic test accurately and consistently diagnoses benign growths, or nodules, on the thyroid gland, according to a study from Chile. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
"We have developed a 'gene signature' that effectively identifies benign thyroid nodules," said Hernan Gonzalez, MD, PhD, associate professor at the Pontifical Catholic University of Chile in Santiago. "This test is potentially useful to identify patients who do not require surgery."
The thyroid gland, located in the front of ...
Steroid hormone may be indicator of infant distress
2013-06-17
During labor and delivery, infants preferentially secrete a different stress hormone than their mothers do, according to a new clinical study. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco and published in the open access journal, PLoS One.
A primary component of good pregnancy care is the ability to quickly recognize and respond to fetal distress. Since the stress hormone cortisol is found in much higher concentrations than the hormone corticosterone, it has received greater attention as an indicator of stress ...
Dietary supplement linked to increased muscle mass in the elderly
2013-06-17
SAN FRANCISCO-- A supplemental beverage used to treat muscle-wasting may help boost muscle mass among the elderly, according to a new study. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.
The supplemental beverage, called Juven®, contains three amino acids, including arginine. Amino acids are the building blocks of proteins, and are required for cell growth and repair. The amino acid arginine is especially important because it increases growth-hormone production, which causes the body to produce a critical protein called ...
Drugs used to treat heart failure and high blood pressure may help decrease obesity
2013-06-17
SAN FRANCISCO-- A type of drug normally used to treat heart failure and high blood pressure helped prevent weight gain and other complications related to a high-fat diet in an animal study. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.
Weight gain, especially around the waist, and high blood pressure, combine with other abnormalities to form a cluster of diseases known as metabolic syndrome, which increases the risk of heart disease, diabetes and other serious illnesses. With obesity rates climbing in developed countries ...
Too little sleep may trigger the 'munchies' by raising levels of an appetite-controlling molecule
2013-06-17
SAN FRANCISCO--Insufficient sleep may contribute to weight gain and obesity by raising levels of a substance in the body that is a natural appetite stimulant, a new study finds. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.
The researchers found that when healthy, lean, young adults received only 4.5 hours of sleep a night, they had higher daytime circulating, or blood, levels of a molecule that controls the pleasurable aspects of eating, compared with when they slept 8.5 hours.
"Past experimental studies show that ...
Weight loss improves memory and alters brain activity in overweight women
2013-06-17
SAN FRANCISCO-- Memory improves in older, overweight women after they lose weight by dieting, and their brain activity actually changes in the regions of the brain that are important for memory tasks, a new study finds. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.
"Our findings suggest that obesity-associated impairments in memory function are reversible, adding incentive for weight loss," said lead author Andreas Pettersson, MD, a PhD student at Umea University, Umea, Sweden.
Previous research has shown that obese ...
Being overweight linked to excess stress hormones after eating
2013-06-17
SAN FRANCISCO-- Overweight and obese men secrete greater amounts of stress hormones after eating, which may make them more susceptible to disease, a new observational study finds. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
Excess weight and obesity are a global health problem, and medical researchers are seeking different approaches to reduce the burden of disease. One way to do this is by identifying differences in hormonal regulation between overweight and lean people in response to various situations, including ...
The Rett Syndrome protein surrenders some of its secrets
2013-06-17
Discovery of a mutant gene responsible for a disease is a milestone, but for most conditions, it may be only a first step towards a treatment or cure. Understanding Rett Syndrome, an autism spectrum disorder, is further complicated by the fact that the implicated gene controls a suite of other genes. Two papers, published in today's Nature Neuroscience and Nature, reveal key steps in how mutations in the gene for methyl CpG-binding protein (MECP2) cause the condition. The Rett Syndrome Research Trust (RSRT) funded this work with generous support from partners Rett Syndrome ...
Drug boosts fat tissue's calorie-burning ability in lab
2013-06-17
SAN FRANCISCO-- A drug that mimics the activity of thyroid hormone significantly increases the amount of energy burned by fat tissue and promotes weight loss, an animal study of metabolism finds. The results were presented Sunday at The Endocrine Society's 95th Annual Meeting in San Francisco.
Humans and other mammals have two kinds of fat, or adipose, tissue, which are referred to by color: white or brown. White adipose tissue, or WAT, has low energy-burning capacity. Because of this, WAT is associated with weight gain and obesity, as well as other conditions related ...
Testosterone therapy improves sexual function after uterus and ovary removal
2013-06-17
SAN FRANCISCO-- High doses of testosterone significantly improve sexual function among women who have had their uterus and ovaries surgically removed, a clinical study demonstrates. The results were presented Sunday at The Endocrine Society's 95th Annual Meeting in San Francisco.
Surgical removal of the uterus, or hysterectomy, and the ovaries, which is called oophorectomy, is performed to treat various diseases, including cancer. Hysterectomy is also performed as an elective sterilization, usually among older women, and may be combined with oophorectomy if ovarian disease ...